Chargement en cours...
Androgen receptor expression and breast cancer mortality in a population-based prospective cohort
PURPOSE: The increase in clinical trials with androgen receptor (AR)-targeting drugs emphasizes the need of clarifying the role of AR expression in different breast cancer subtypes. AR confers good prognosis in estrogen receptor positive (ER+) breast cancer, but its role in ER-negative (ER−) breast...
Enregistré dans:
| Publié dans: | Breast Cancer Res Treat |
|---|---|
| Auteurs principaux: | , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Springer US
2017
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5602002/ https://ncbi.nlm.nih.gov/pubmed/28643022 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-017-4343-0 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|